Integration of a Cas12a-mediated DNAzyme actuator with efficient RNA extraction for ultrasensitive colorimetric detection of viral RNA

• Published in: Biosensors & bioelectronics 2024-09, Vol.260, p.116429, Article 116429
• Main Authors: Xiao, Huyan, Xu, JingYang, Liu, Yanming, Feng, Wei, Pang, Bo, Tao, Jeffrey, Zhang, Hongquan
• Format: Article
• Language: English
• Subjects: Bacterial Proteins; Biosensing Techniques - methods; Colorimetry - methods; COVID-19 - diagnosis; COVID-19 - virology; CRISPR-Associated Proteins - chemistry; CRISPR-Associated Proteins - isolation & purification; DNA, Catalytic - chemistry; Endodeoxyribonucleases - chemistry; Feces - chemistry; Feces - virology; Gargle; Humans; Infectious disease; Isothermal amplification; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques - methods; On-site application; RNA, Viral - genetics; RNA, Viral - isolation & purification; Saliva; Saliva - chemistry; Saliva - virology; SARS-CoV-2; SARS-CoV-2 - genetics; SARS-CoV-2 - isolation & purification
• ISSN: 0956-5663; 1873-4235; 1873-4235
• DOI: 10.1016/j.bios.2024.116429

Developing highly sensitive and specific on-site tests is imperative to strengthen preparedness against future emerging infectious diseases. Here, we describe the construction of a Cas12a-mediated DNAzyme actuator capable of converting the recognition of a specific DNA sequence into an amplified colorimetric signal. To address viral RNA extraction challenges for on-site applications, we developed a rapid and efficient method capable of lysing the viral particles, preserving the released viral RNA, and concentrating the viral RNA. Integration of the DNAzyme actuator with the viral RNA extraction method and loop-mediated isothermal amplification enables a streamlined colorimetric assay for highly sensitive colorimetric detection of respiratory RNA viruses in gargle and saliva. This assay can detect as few as 83 viral particles/100 μL in gargle and 166 viral particles/100 μL in saliva. The entire assay, from sample processing to visual detection, was completed within 1 h at a single controlled temperature. We validated the assay by detecting SARS-CoV-2 in 207 gargle and saliva samples, achieving a clinical sensitivity of 96.3 % and specificity of 100%. The assay is adaptable for detecting specific nucleic acid sequences in other pathogens and is suitable for resource-limited settings. [Display omitted]